Release of Amphotericin B from Delivery Systems and its Action Against Fungal and Mammalian Cells

References

• J. Adler‐Moore, and R. Proffitt.(1993). Development, characterization, efficacy and mode of action of AmBisome, a unilamellar liposomal formulation of amphotericin B J. Liposome Res 3:429–450.
   Google Scholar
• W. Beggs.(1994). Physicochemical cell damage in relation to lethal amphotericin B action Antimicrob. Ag. Chemother 38:363–364.
   PubMed Web of Science ®Google Scholar
• J. Bolard, P. Legrand, F. Heitz, and B. Cybulska.(1991). One sided action of amphotericin B on cholesterol‐containing membranes is determined by its self association in the medium Biochem 30:5707–5715.
   PubMed Web of Science ®Google Scholar
• J. Brajtburg, S. Elberg, G. Kobayashi, and G. Medoff.(1994). Amphotericin B incorporated into egg lecithin‐bile salt Mixed Micelles: molecular and cellular aspects relevant to therapeutic efficacy in experimental mycosis Antimicrob. Ag. Chemother 38:300–306.
   PubMed Web of Science ®Google Scholar
• R. Chopra, S. Blair, J. Strang, P. Cervi, K. Patterson, and A. Goldstone.(1991). Liposomal amphotericin B (AmBisome) in the treatment of fungal infections in neutropenic patients J. Antimicrob. Chemother 28:93–104.
   PubMed Web of Science ®Google Scholar
• R. Janknegt, S. de Marie, I. Bakker‐Woudenberg, and D. Crommelin.(1992). Liposomal and lipid formulations of amphotericin B: Clinical pharmacokinetics Clin. Pharmacokin 23:279–291.
   PubMed Web of Science ®Google Scholar
• V. Joly, J. Bolard, L. Saint‐Julien, C. Carbon, and P. Yeni.(1992). Influence of the phospholipid/amphotericin B ratio and the phospholipid type on the in vitro renal cell toxicity and fungicidal activity of lipid associated‐amphotericin B formulations Antimicrob. Ag. Chemother 36:262–266.
   PubMed Web of Science ®Google Scholar
• R. Juliano, C. Grant, K. Barber, and N. Kalp.(1987). Mechanism of the selective toxicity of amphotericin B incorporated into liposomes Mol. Pharmacol 31:1–11.
   PubMed Web of Science ®Google Scholar
• S. Jullien, A. Contrepois, J. Sligh, Y. Domart, P. Yeni, J. Brajtburg, G. Medoff, and J. Bolard.(1989). Study of the effect of liposomal amphotericin B on Candida albicans, Cryptococcus neoformans and erythocytes by using small unilamellar vesicles prepared from saturated phospholipids Antimicrob. Ag. Chemother 33:345–349.
   PubMed Web of Science ®Google Scholar
• S. Jullien, J. Brajtburg, and J. Bolard.(1990). Affinity of amphotericin B for phosphatidylcholine vesicles as a determinant of the in vitro cellular toxicity of liposomal preparations Biochim. Biophys. Acta 1201:39–45.
   Google Scholar
• H. Lambing, B. Wolf, and S. Hansel.(1993). Temperature effect on the aggregation state and activity of amphotericin B Biochim. Biophys. Acta 1152:185–188.
   PubMed Web of Science ®Google Scholar
• P. Legrand, E. Romero, B. Cohen, and J. Bolard.(1992). Effects of aggregation and solvent on the toxicity of amphotericin B to human erythrocytes Antimicrob. Ag. Chemother 36:2518–2522.
   PubMed Web of Science ®Google Scholar
• J. Litchfield, and F. Wilcoxon.(1948). A simplified method of evaluating dose‐effect experiments J. Pharmacol. Exp. Techn 96:99–113.
   Web of Science ®Google Scholar
• G. Lopez‐Berestein, G. Bodey, V. Fainstein, M. Keating, L. Frankel, B. Zeluff, L. Gentry, and K. Mehta.(1989). Treatment of systemic fungal infections with liposomal amphotericin B Arch. Intern. Med 149:2533–2536.
   PubMed Web of Science ®Google Scholar
• J. Mazerski, J. Bolard, and E. Borowski.(1982). Self‐association of some polyene macrolide antibiotic in aqueous media Biochim. Biophys. Acta 719:11–17.
   Web of Science ®Google Scholar
• R. Mehta, G. Lopez‐Berestein, R. Hopfer, K. Mills, and R. Juliano.(1984). Liposomal amphotericin B is toxic to fungal cells but not to mammalian cells Biochim. Biophys. Acta 770:230–234.
   PubMed Web of Science ®Google Scholar
• S. Pahls, and A. Schaffner.(1994). Comparison of the activity of free and liposomal amphotericin B in vitro and in a model of systemic and localized murine candidiasis J. Inf. Dis 169:1057–1061.
   PubMed Web of Science ®Google Scholar
• W. Perkins, S. Minchey, L. Boni, C. Swenson, M. Popescu, R. Pasternack, and A. Janoff.(1992). Amphotericin B‐phospholipid interactions responsible for reduced mammalian cell toxicity Biochim. Biophys. Acta 1107:271–282.
   PubMed Web of Science ®Google Scholar
• N. Rajagopalan, and W. Chow.(1986). A study of the inclusion complex of amphotericin B with gamma.‐Cyclodextrin Int. J. Pharm 29:161–168.
   Web of Science ®Google Scholar
• E. Ralf, A. Khazindar, K. Barber, and C. Grant.(1991). Comparative in vitro effects of liposomal amphotericin B, amphotericin B‐deoxycholate, and free amphotericin B against fungal strains determined by using MIC and minimal lethal concentration susceptibility studies and time‐kill curves Antimicrob. Ag. Chemother 35:188–191.
   PubMed Web of Science ®Google Scholar
• J. Sculier, A. Coune, F. Meunier, C. Brassine, C. Laduron, C. Hollaert, N. Colette, C. Heymans, and J. Klatersky.(1988). Pilot study of amphotericin B entrapped in sonicated liposomes in cancer patients with fungal infections Eur. J. Cancer Clin. Oncol 24:527–538.
   PubMedGoogle Scholar
• F. Szoka, D. Milholland, and M. Barza.(1987). Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome‐intercalated amphotericin B Antimicrob. Ag. Chemother 31:421–429.
   PubMed Web of Science ®Google Scholar
• E. van Etten, M. Kate, L. Stearne, and I. Bakker‐Woudenberg.(1995). Amphotericin B liposomes with prolonged circulation in blood: in vitro antifungal activity, toxicity and efficacy in systemic candidiasis in leukopenic mice Antimicrob. Ag. Chemother 39:1954–1958.
   PubMed Web of Science ®Google Scholar
• N. Witzke, and R. Bittman.(1984). Dissociation kinetics and equilibrium binding properties of polyene antibiotic complexes with phosphtidylcholine/sterol vesicles Biochem 23:1668–1674.
   PubMed Web of Science ®Google Scholar